NCGM, Fujita Univ. to Join NIH’s Immunoglobulin Trial for COVID-19

December 24, 2020
The National Center for Global Health and Medicine (NCGM) and Fujita Health University have launched an investigator-led study to assess the safety and efficacy of immunoglobulins for COVID-19 as part of a global trial led by the National Institutes of...read more